These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35240713)

  • 21. Homozygous familial hypercholesterolaemia in Vietnam: Case series, genetics and cascade testing of families.
    Truong TH; Kim NT; Nguyen MNT; Pang J; Hooper AJ; Watts GF; Do DL
    Atherosclerosis; 2018 Oct; 277():392-398. PubMed ID: 30270076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening in children for familial hypercholesterolaemia: start now.
    Groselj U; Wiegman A; Gidding SS
    Eur Heart J; 2022 Sep; 43(34):3209-3212. PubMed ID: 35511818
    [No Abstract]   [Full Text] [Related]  

  • 23. Molecular epidemiology of familial hypercholesterolaemia.
    Defesche JC; Kastelein JJ
    Lancet; 1998 Nov; 352(9141):1643-4. PubMed ID: 9853432
    [No Abstract]   [Full Text] [Related]  

  • 24. Examining barriers to cascade screening for familial hypercholesterolemia in the United States.
    Andersen R; Andersen L
    J Clin Lipidol; 2016; 10(2):225-7. PubMed ID: 27055953
    [No Abstract]   [Full Text] [Related]  

  • 25. Cascade screening for familial hypercholesterolaemia: implications of a pilot study for national screening programmes.
    Marks D; Thorogood M; Neil SM; Humphries SE; Neil HA
    J Med Screen; 2006; 13(3):156-9. PubMed ID: 17007658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysis.
    Warner M
    Ann Clin Biochem; 2008 Jan; 45(Pt 1):114. PubMed ID: 18275690
    [No Abstract]   [Full Text] [Related]  

  • 27. Universal Screening for Familial Hypercholesterolemia in Children.
    Klančar G; Grošelj U; Kovač J; Bratanič N; Bratina N; Trebušak Podkrajšek K; Battelino T
    J Am Coll Cardiol; 2015 Sep; 66(11):1250-1257. PubMed ID: 26361156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.
    Marks D; Wonderling D; Thorogood M; Lambert H; Humphries SE; Neil HA
    Health Technol Assess; 2000; 4(29):1-123. PubMed ID: 11109029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Universal screening of cholesterol in children.
    Kwiterovich PO; Gidding SS
    Clin Cardiol; 2012 Nov; 35(11):662-4. PubMed ID: 22930527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. People at risk of familial hypercholesterolaemia should have DNA test, says NICE.
    BMJ; 2017 Nov; 359():j5112. PubMed ID: 29097374
    [No Abstract]   [Full Text] [Related]  

  • 31. Prevalence of Familial Hypercholesterolemia in Adolescents: Potential Value of Universal Screening?
    Pang J; Martin AC; Mori TA; Beilin LJ; Watts GF
    J Pediatr; 2016 Mar; 170():315-6. PubMed ID: 26690851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Familial hypercholesterolaemia: too many lost opportunities.
    Cuchel M; McGowan MP
    Lancet; 2021 Nov; 398(10312):1667-1668. PubMed ID: 34506745
    [No Abstract]   [Full Text] [Related]  

  • 33. Responses to 'Decision to reject screening for familial hypercholesterolaemia is flawed' by Wald and Martin.
    Marshall J; Shortland Obe G; Hillier S; Brownsword R; Steele B
    Arch Dis Child; 2022 Jan; 107(1):102. PubMed ID: 34289993
    [No Abstract]   [Full Text] [Related]  

  • 34. Implementation of a Machine-Learning Algorithm in the Electronic Health Record for Targeted Screening for Familial Hypercholesterolemia: A Quality Improvement Study.
    Sheth S; Lee P; Bajaj A; Cuchel M; Hajj J; Soffer DE; Webb G; Hossain E; Borovskiy Y; Risman M; Myers KD; Wilemon KA; Rader DJ; Jacoby D
    Circ Cardiovasc Qual Outcomes; 2021 Jun; 14(6):e007641. PubMed ID: 34107738
    [No Abstract]   [Full Text] [Related]  

  • 35. Reaching detection targets in familial hypercholesterolaemia: Comparison of identification strategies.
    Wald DS; Bestwick JP
    Atherosclerosis; 2020 Jan; 293():57-61. PubMed ID: 31837509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA sequencing in familial hypercholesterolaemia: the next generation.
    Lazarte J; Hegele RA
    Eur J Prev Cardiol; 2021 Jul; 28(8):873-874. PubMed ID: 33623969
    [No Abstract]   [Full Text] [Related]  

  • 37. Global Familial Hypercholesterolaemia Studies Collaboration (FHSC).
    Stock JK
    Atherosclerosis; 2021 Nov; 337():57-58. PubMed ID: 34686380
    [No Abstract]   [Full Text] [Related]  

  • 38. Reverse Cascade Screening for Familial Hypercholesterolemia.
    Vinson A; Guerra L; Hamilton L; Wilson DP; Fnla
    J Pediatr Nurs; 2019; 44():50-55. PubMed ID: 30683281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular testing for familial hypercholesterolaemia-associated mutations in a UK-based cohort: development of an NGS-based method and comparison with multiplex polymerase chain reaction and oligonucleotide arrays.
    Reiman A; Pandey S; Lloyd KL; Dyer N; Khan M; Crockard M; Latten MJ; Watson TL; Cree IA; Grammatopoulos DK
    Ann Clin Biochem; 2016 Nov; 53(6):654-662. PubMed ID: 26748104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Management of familial heterozygous hypercholesterolaemia. Position paper of the Polish Lipid Expert Forum].
    Rynkiewicz A; Cybulska B; Banach M; Filipiak KJ; Guzik T; Idzior Waluś B; Imiela J; Jankowski P; Kłosiewicz Latoszek L; Limon J; Myśliwiec M; Opolski G; Steciwko A; Stępińska J; Zdrojewski T;
    Kardiol Pol; 2013; 71(1):107-11. PubMed ID: 23348551
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.